Home » Topics » BioWorld Science

BioWorld Science
RSS

AcuraStem patents 1-phosphatidylinositol 3-phosphate 5-kinase inhibitors

March 27, 2019

Amgen describes new Mcl-1 inhibitors

March 27, 2019

Lysophosphatidic acid receptor 1 antagonists identified at Lilly

March 27, 2019

Roche discloses compounds binding E3 ubiquitin-protein ligase

March 27, 2019

Shanghai Meizer Pharmaceuticals patents ALK kinase receptor inhibitors

March 27, 2019

ALK-4290 demonstrates safety and improvement in BCVA score in patients with nAMD

March 27, 2019

Topline data presented from phase II advanced liver cancer study of namodenoson

March 27, 2019

NSD2 is a novel biomarker and potential epigenetic target for retinoblastoma

March 27, 2019

FDA clears Selvita's IND application to conduct phase I study of SEL-120

March 27, 2019

ONO-ST-468 suppresses excessive GH secretion in GHRH/arginine-induced GH hypersecretion model

March 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...